French pharmaceutical company Servier has swooped on Agios Pharma’s marketed and experimental cancer drugs, buying the entire franchise in a deal that leaves the US biopharma focused on genetic ...

Shares in Agios Pharma lost nearly half their value in pre-market trading today after it posted mixed clinical results from a phase 3 trial of its sickle cell disease (SCD) therapy mitapivat, sending ...

Chart does not reflect overnight price.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Abstract: As satellite communications have to keep up with the increasing demand of higher data rates, the new high throughput satellite systems have to implement several techniques to increase the ...

Get the latest Agios Pharmaceuticals, Inc. (AGIO) stock news and headlines to help you in your trading and investing decisions.